Additionally, immune function and immune cells were analyzed based on risk groups, revealing immunomodulatory effects of CNN3 and LGR4, with LGR4 known to maintain AML stem cell function (15, 16). This evidence concerns the gene CNN3 and acute myeloid leukemia.